Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 1, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Sublingual immunotherapy.

Sandra Y Lin1, Bryan Leatherman

  • 1Department of Otolaryngology-Head & Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA. Slin30@jhmi.edu

Otolaryngologic Clinics of North America
|May 31, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Air Pollution and Particulate Matter: Implications in Upper Airway Disease.

International forum of allergy & rhinology·2026
Same author

Tapering Biologic Therapy in Chronic Rhinosinusitis With Nasal Polyps.

JAMA otolaryngology-- head & neck surgery·2025
Same author

Medical Therapy Algorithm With Telehealth Reduces Procedures and Transfers for Peritonsillar Abscess.

The Laryngoscope·2025
Same author

External Validation of a Multivariable Diagnostic Prediction Model for Acute Invasive Fungal Rhinosinusitis in Tertiary Care Settings.

International forum of allergy & rhinology·2025
Same author

Evaluation and treatment of rhinosinusitis with primary antibody deficiency in children: Evidence-based review with recommendations.

International forum of allergy & rhinology·2024
Same author

Evaluation and treatment of rhinosinusitis with primary antibody deficiency in adults: Evidence-based review with recommendations.

International forum of allergy & rhinology·2023
Same journal

Little Tube; Big Problems: Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026
Same journal

Current State of Button Battery Ingestion Injuries.

Otolaryngologic clinics of North America·2026
Same journal

Diagnostic Algorithm for Eustachian Tube Dysfunction and Indications for Balloon Dilation of the Eustachian Tube.

Otolaryngologic clinics of North America·2026
Same journal

Patulous Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026
Same journal

Revisiting Eustachian Tube Anatomy and Physiology.

Otolaryngologic clinics of North America·2026
Same journal

Glottic Stenosis.

Otolaryngologic clinics of North America·2026
See all related articles

Sublingual immunotherapy (SLIT) is a safe and effective treatment for allergic rhinitis, showing promise in preventing new allergies and improving asthma control. Ongoing research aims to establish optimal dosing for broader application.

Area of Science:

  • Allergy and Immunology
  • Clinical Therapeutics

Background:

  • Sublingual immunotherapy (SLIT) is a well-established treatment for allergic rhinitis in Europe.
  • Interest and research in SLIT are growing in the United States.
  • SLIT demonstrates immunologic effects comparable to subcutaneous immunotherapy.

Purpose of the Study:

  • To review the safety and efficacy of SLIT for allergic rhinitis.
  • To explore the potential of SLIT in preventing further allergic sensitization and improving asthma outcomes.
  • To address challenges in translating European dosing to the US and identify effective dosage ranges.

Main Methods:

  • Review of existing clinical studies and immunologic data on SLIT.
  • Analysis of safety and efficacy in allergic rhinitis treatment.

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Related Experiment Videos

Last Updated: Jun 1, 2026

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

  • Evaluation of SLIT's impact on new sensitizations and asthma development.

    • Main Results:

    • SLIT is safe and effective for allergic rhinitis.
    • SLIT induces immunologic changes similar to injection immunotherapy.
    • SLIT may offer preventive benefits against new allergies and asthma.

    Conclusions:

    • SLIT is a viable therapeutic option for allergic rhinitis with potential disease-modifying effects.
    • Standardization and dosing require further investigation for US implementation.
    • Continued research is essential to optimize SLIT protocols and expand its use.